Phenotypic and Genomic Analyses of Burkholderia stabilis Clinical Contamination, Switzerland.

Bcc Burkholderia stabilis DNA Switzerland bacteria hospital-associated infections resistance virulence whole-genome sequencing

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 21 5 2019
pubmed: 21 5 2019
medline: 7 1 2020
Statut: ppublish

Résumé

A recent hospital outbreak related to premoistened gloves used to wash patients exposed the difficulties of defining Burkholderia species in clinical settings. The outbreak strain displayed key B. stabilis phenotypes, including the inability to grow at 42°C; we used whole-genome sequencing to confirm the pathogen was B. stabilis. The outbreak strain genome comprises 3 chromosomes and a plasmid, sharing an average nucleotide identity of 98.4% with B. stabilis ATCC27515 BAA-67, but with 13% novel coding sequences. The genome lacks identifiable virulence factors and has no apparent increase in encoded antimicrobial drug resistance, few insertion sequences, and few pseudogenes, suggesting this outbreak was an opportunistic infection by an environmental strain not adapted to human pathogenicity. The diversity among outbreak isolates (22 from patients and 16 from washing gloves) is only 6 single-nucleotide polymorphisms, although the genome remains plastic, with large elements stochastically lost from outbreak isolates.

Identifiants

pubmed: 31107229
doi: 10.3201/eid2506.172119
pmc: PMC6537712
doi:

Substances chimiques

Fatty Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1084-1092

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Références

PLoS One. 2014 Feb 04;9(2):e87991
pubmed: 24505344
J Clin Microbiol. 2003 Jul;41(7):3181-6
pubmed: 12843061
J Antimicrob Chemother. 2002 Aug;50(2):265-9
pubmed: 12161410
Front Microbiol. 2016 Jun 08;7:877
pubmed: 27375597
PLoS One. 2014 Aug 25;9(8):e104986
pubmed: 25153194
Diagn Microbiol Infect Dis. 2013 Oct;77(2):126-8
pubmed: 23891221
Appl Microbiol Biotechnol. 2016 Jun;100(12):5215-29
pubmed: 27115756
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Genome Res. 2008 May;18(5):729-41
pubmed: 18403782
Genome Announc. 2016 Oct 27;4(5):
pubmed: 27789640
Infect Immun. 2008 Jan;76(1):38-47
pubmed: 17967860
Microbiology. 2011 Nov;157(Pt 11):3124-3137
pubmed: 21835880
Int J Infect Dis. 2015 Apr;33:71-4
pubmed: 25578264
Front Mol Biosci. 2016 May 03;3:16
pubmed: 27200362
J Bacteriol. 2009 Jan;191(1):261-77
pubmed: 18931103
Am J Infect Control. 2015 Mar 1;43(3):266-8
pubmed: 25557770
J Hosp Infect. 2008 Nov;70(3):241-5
pubmed: 18799235
J Gen Microbiol. 1973 Feb;74(2):275-9
pubmed: 4697826
Emerg Infect Dis. 2007 Mar;13(3):458-61
pubmed: 17552100
BMC Bioinformatics. 2013 Feb 21;14:60
pubmed: 23432962
J Clin Microbiol. 1991 Sep;29(9):1822-30
pubmed: 1774302
J Antimicrob Chemother. 2009 Oct;64(4):801-9
pubmed: 19633000
J Clin Microbiol. 2007 Jul;45(7):2270-3
pubmed: 17507509
Genome Announc. 2016 Nov 17;4(6):
pubmed: 27856590
Euro Surveill. 2017 Dec;22(49):
pubmed: 29233255
Stand Genomic Sci. 2010 Jan 28;2(1):117-34
pubmed: 21304684
Bioinformatics. 2005 Aug 15;21(16):3422-3
pubmed: 15976072
J Clin Microbiol. 2001 Mar;39(3):1073-8
pubmed: 11230429
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):81-91
pubmed: 17220447
J Clin Microbiol. 2014 May;52(5):1529-39
pubmed: 24574292
Nucleic Acids Res. 2015 Jul 1;43(W1):W237-43
pubmed: 25948579
J Clin Microbiol. 2008 Apr;46(4):1470-3
pubmed: 18256220
Science. 2009 Oct 9;326(5950):236-7
pubmed: 19815760
Nat Genet. 2003 Sep;35(1):32-40
pubmed: 12910271
J Clin Microbiol. 2000 Mar;38(3):1042-7
pubmed: 10698993
Infect Genet Evol. 2018 Apr;59:1-6
pubmed: 29367013
Bioinformatics. 2000 Oct;16(10):944-5
pubmed: 11120685
Antonie Van Leeuwenhoek. 2014 Jul;106(1):57-65
pubmed: 24633913
J Appl Microbiol. 2008 Jun;104(6):1539-51
pubmed: 18217926
J Clin Microbiol. 1997 Jun;35(6):1398-403
pubmed: 9163452
J Hosp Infect. 2005 Jan;59(1):46-52
pubmed: 15571853
Int J Syst Bacteriol. 1997 Oct;47(4):1188-200
pubmed: 9336927
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Bacteriol. 2007 Feb;189(3):807-17
pubmed: 17114252
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH